luzindole has been researched along with kynuramine in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (kynuramine) | Trials (kynuramine) | Recent Studies (post-2010) (kynuramine) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 190 | 0 | 41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonior, J; Goralska, M; Jastrzebska, M; Jaworek, J; Leja-Szpak, A; Link-Lenczowski, P; Nawrot-Porabka, K; Pierzchalski, P | 1 |
1 other study(ies) available for luzindole and kynuramine
| Article | Year |
|---|---|
Kynuramines induce overexpression of heat shock proteins in pancreatic cancer cells via 5-hydroxytryptamine and MT1/MT2 receptors.
Topics: Cell Line, Tumor; Heat-Shock Proteins; Humans; Ketanserin; Kynuramine; Melatonin; Pancreatic Neoplasms; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Serotonin; Tropanes; Tryptamines; Tryptophan | 2015 |